Search Results

How to Keep Your Kids Hydrated in the Summer Heat

Keep Your Children Hydrated and Healthy in Summer Heat

The heat has settled in, and that means it’s even more important to make sure your kids are staying properly hydrated.

Lauren Thomas, MSN, APRN, CPNP-PC, CPN

Lauren Thomas is an advanced practice registered nurse (APRN) and certified pediatric nurse practitioner – primary care (CPNP-PC) with the Orlando Health Arnold Palmer Hospital for Children. She works in the pediatric hematology-oncology unit at the Haley Center for Children’s Cancer and Blood Disorders, and her experience includes:

CIBMTR Research Database

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma

Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

A Phase II Trial Evaluating Chemotherapy followed by Response-Based Reduced Radiation Therapy for Patients with Central Nervous System Germinomas

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

A Phase 2 Trial of Chemotherapy Followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients With Localized Non-Germinomatous Central Nervous System Germ Cell Tumor